Results 141 to 150 of about 19,280 (221)

Terlipressin for hepatorenal syndrome: The practical choice for clinicians. [PDF]

Clin Liver Dis (Hoboken), 2023
Wahid N, Duarte-Rojo A, Boike JR.
europepmc   +1 more source

Mixed lymphocyte culture and graft rejection. [PDF]

, 1973
Bethell, D, Corman, J, Fiala, JM, Ishikawa, M, Iwatsuki, S, Johansen, TS, Kashiwagi, N, Starzl, TE   +7 more
core  

Challenges in the Treatment of Hepatorenal Syndrome-Acute Kidney Injury: A US Chart Review of Treatment Patterns and Survival Outcomes. [PDF]

JGH Open
Sanyal AJ, Reddy KR, Brown KA, Landis CS, Cullaro G, Huang X, Kelkar SS, Raina R, Corman S, Kebede N, Edmundson P, Jamil K, Allegretti AS.   +12 more
europepmc   +1 more source

Predictors of response to terlipressin therapy in hepatorenal syndrome: Metabolomic and proteomic analysis from the CONFIRM trial. [PDF]

Hepatol Commun
Allegretti AS, Levitsky J, Sharma P, Ouyang T, Jamil K, Silvey S, Bajaj JS.   +6 more
europepmc   +1 more source

Liver Transplantation [PDF]

, 1995
Kahn, D, Starzl, TE
core  

A new multisystem ERCC1-hepatorenal syndrome: insights from a clinical cohort, molecular pathogenesis, and management guidelines. [PDF]

Eur J Hum Genet
White SM, Wondergem AP, Breet I, Dittmaier M, Bell K, Richmond CM, Hardikar W, Bhatia K, Quinlan C, Orchard D, D'Souza A, Chazin WJ, Smith C, Sparkes R, Lam S, Carter A, Hopkin RJ, Khendek L, Sullivan BR, Becher N, Simonsen AKW, Kvistgaard H, Dempsey K, Miethke AG, Gregersen PA, Phillips E, Luijsterburg MS.   +26 more
europepmc   +1 more source

Mapping the hemodynamic effects of terlipressin in patients with hepatorenal syndrome using advanced magnetic resonance imaging. [PDF]

JHEP Rep
Danielsen KV, Hove JD, Nabilou P, Kronborg TM, Wiese S, Siebner HR, Scott R, Francis ST, Aithal GP, Møller S, Bendtsen F.   +10 more
europepmc   +1 more source

Cefotaxime desensitization [PDF]

, 1993
Bogner, Johannes R., Hehlmann, R., Hofmeister, F., Papakonstantino, G.   +3 more
core   +1 more source

Hepatorenal syndrome: Paving a pathway from a fatal condition to an opportunity to preserve kidney function. [PDF]

World J Nephrol
Gonzalez FM.
europepmc   +1 more source

A Study of the Clinical Profiles of Patients With Hepatorenal Syndrome. [PDF]

Cureus
Borle A, Kanitkar S, Bagare PC, Ahlawat M, Ande SP.   +4 more
europepmc   +1 more source